{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:38:57Z","timestamp":1794472737097,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Many questions concerning Turner syndrome (TS) remain unresolved, such as the long-term complications and, therefore, the optimal care setting for adults. The primary aim of this long-term cohort study was to estimate the incidence of comorbid conditions along the life course.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 160 Italian patients with TS diagnosed from 1967 to 2010 were regularly and structurally monitored from the diagnosis to December 2019 at the University Hospital of Bologna using a structured multidisciplinary monitoring protocol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study cohort was followed up for a median of 27\u00a0years (IQR 12\u201342). Autoimmune diseases were the comorbid condition with the highest incidence (61.2%), followed by osteoporosis and hypertension (23.8%), type 2 diabetes (16.2%) and tumours (15.1%). Median age of onset ranged from 22\u00a0years for autoimmune diseases to 39\u00a0years for type 2 diabetes. Malignant tumours were the most prominent type of neoplasm, with a cumulative incidence of 11.9%. Papillary thyroid carcinoma was the most common form of cancer, followed by skin cancer and cancer of the central nervous system. Only one major cardiovascular event (acute aortic dissection) was observed during follow-up. No cases of ischaemic heart disease, heart failure, stroke or death were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This cohort study confirms the need for continuous, structured and multidisciplinary lifelong monitoring of TS, thus ensuring the early diagnosis of important comorbid conditions, including cancer, and their appropriate and timely treatment. In addition, these data highlight the need for the increased surveillance of specific types of cancer in TS, including thyroid carcinoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-022-01853-z","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T06:02:51Z","timestamp":1659160971000},"page":"2247-2256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"A.","family":"Gambineri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tamburrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Corzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cecchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dionese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ibarra-Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Menab\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"di Dalmazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pelusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zavatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Virdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","volume":"15","author":"CH Gravholt","year":"2019","unstructured":"Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH (2019) Turner Syndrome: mechanisms and management. Nat Rev Endocrinol 15:601\u2013614. https:\/\/doi.org\/10.1038\/s41574-019-0224-4","journal-title":"Nat Rev Endocrinol"},{"key":"1853_CR2","doi-asserted-by":"publisher","unstructured":"Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, et al.; Fifth International Symposium on Turner Syndrome. Recommendations for the diagnosis and management of Turner Syndrome. J Clin Endocrinol Metab. 2001; 86: 3061\u20133069. https:\/\/doi.org\/10.1210\/jcem.86.7.7683.","DOI":"10.1210\/jcem.86.7.7683"},{"key":"1853_CR3","doi-asserted-by":"publisher","first-page":"E1517","DOI":"10.1210\/jc.2011-0346","volume":"96","author":"K Freriks","year":"2011","unstructured":"Freriks K, Timmermans J, Beerendonk CCM, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DDM, Smeets DFCM, Kunst DHPM, Hermus ARMM et al (2011) Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner Syndrome. J Clin Endocrinol Metab 96:E1517\u2013E1526. https:\/\/doi.org\/10.1210\/jc.2011-0346","journal-title":"J Clin Endocrinol Metab"},{"key":"1853_CR4","doi-asserted-by":"publisher","unstructured":"Fiot E, Z\u00e9naty D, Boizeau P, Haignere J, Dos Santos S, L\u00e9ger J, French Turner Syndrome Study Group. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner Syndrome, from childhood to early adulthood. Eur J Endocrinol 2019;180: 397\u2013406. https:\/\/doi.org\/10.1530\/EJE-18-0878.","DOI":"10.1530\/EJE-18-0878"},{"key":"1853_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1210\/edrv.23.1.0457","volume":"23","author":"M Elsheikh","year":"2002","unstructured":"Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner\u2019s syndrome in adulthood. Endocr Rev 23:120\u2013140. https:\/\/doi.org\/10.1210\/edrv.23.1.0457","journal-title":"Endocr Rev"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm K, Juul S, Jouel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay and mortality in Turner Syndrome. J Clin Endocrinol Metab 91:3897\u20133902. https:\/\/doi.org\/10.1210\/jc.2006-0558","journal-title":"J Clin Endocrinol Metab"},{"key":"1853_CR7","doi-asserted-by":"publisher","unstructured":"Mortensen KH, Anderson NH, Gravholt CH. Cardiovascular phenotypes in Turner Syndrome-integrating cardiology, genetics and endocrinology Endocr Rev 33, 677-714 2021. https:\/\/doi.org\/10.1210\/er.2011-1059","DOI":"10.1210\/er.2011-1059"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1210\/jc.2008-1049","volume":"93","author":"MJ Schoemaker","year":"2009","unstructured":"Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2009) Mortality in women with Turner Syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735\u20134742. https:\/\/doi.org\/10.1210\/jc.2008-1049","journal-title":"J Clin Endocrinol Metab"},{"key":"1853_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011501","volume":"8","author":"MM Fuchs","year":"2019","unstructured":"Fuchs MM, Attenhofer Jost C, Babovic-Vuksanovic D, Connolly HM, Egbe A (2019) Long-term outcomes in patients with Turner Syndrome: A 68-year follow-up. J Am Heart Assoc 8:e011501. https:\/\/doi.org\/10.1161\/JAHA.118.011501","journal-title":"J Am Heart Assoc"},{"key":"1853_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/bjc.1996.222","volume":"73","author":"H Hasle","year":"1996","unstructured":"Hasle H, Olsen JH, Nielsen J, Hansen J, Friedrich U, Tommerup N (1996) Occurrence of cancer in women with Turner Syndrome. Br J Cancer 73:1156\u20131159. https:\/\/doi.org\/10.1038\/bjc.1996.222","journal-title":"Br J Cancer"},{"key":"1853_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(08)70033-0","volume":"9","author":"MJ Schoemaker","year":"2008","unstructured":"Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Cancer incidence in women with Turner Syndrome in Britain: a national cohort study. Lancet Oncology 9:239\u2013246. https:\/\/doi.org\/10.1016\/S1470-2045(08)70033-0","journal-title":"Lancet Oncology"},{"issue":"1","key":"1853_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/EJE-20-0702","volume":"184","author":"MH Viuff","year":"2020","unstructured":"Viuff MH, Stochholm K, Lin A, Berglund A, Juul S, Gravholt CH (2020) Cancer occurrence in Turner Syndrome and the effect of sex hormone substitution therapy. Eur J Endocrinol 184(1):79\u201388. https:\/\/doi.org\/10.1530\/EJE-20-0702","journal-title":"Eur J Endocrinol"},{"key":"1853_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ijc.30126","volume":"139","author":"J Ji","year":"2016","unstructured":"Ji J, Zoller B, Sundquist J, Sundquist K (2016) Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a national cohort study. Int J Cancer 139:754\u2013758. https:\/\/doi.org\/10.1002\/ijc.30126","journal-title":"Int J Cancer"},{"key":"1853_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17843286.2020.1805237","volume":"11","author":"C Dejonckheere","year":"2020","unstructured":"Dejonckheere C, Moyson C, de Zegher F, Antonio L, Van Buggenhout G, Decallonne B (2020) Neoplasia in Turner Syndrome: a retrospective cohort study in a tertiary referral centre in Belgium. Acta Clin Belg 11:1\u20137. https:\/\/doi.org\/10.1080\/17843286.2020.1805237","journal-title":"Acta Clin Belg"},{"key":"1853_CR15","doi-asserted-by":"publisher","unstructured":"Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, et al; International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177:G1-G70. doi: https:\/\/doi.org\/10.1530\/EJE-17-0430.","DOI":"10.1530\/EJE-17-0430"},{"key":"1853_CR16","unstructured":"WHO. Measuring obesity: classification and description of anthropometric data. Copenhagen: World Health Organization. 1988."},{"issue":"11","key":"1853_CR17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/00004872-199309000-00004","volume":"1993","author":"Guidelines sub-committee.","year":"1993","unstructured":"Guidelines sub-committee. (1993) guidelines for the management of mild hypertension: memorandum form a World Health Organization\/International Society of Hypertension meeting. J Hypertens 1993(11):905\u2013918. https:\/\/doi.org\/10.1097\/00004872-199309000-00004","journal-title":"J Hypertens"},{"issue":"21","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","volume":"2003","author":"Whitworth JA, for the World Health Organization\/International Society of Hypertension writing group","year":"2003","unstructured":"Whitworth JA, for the World Health Organization\/International Society of Hypertension writing group (2003) World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003(21):1983\u20131992. https:\/\/doi.org\/10.1097\/00004872-200311000-00002","journal-title":"J Hypertens"},{"key":"1853_CR19","doi-asserted-by":"publisher","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsed SE, Laurent S, et al., on behalf of the ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25: 1751\u201362. doi: https:\/\/doi.org\/10.1097\/HJH.0b013e3282f0580f.","DOI":"10.1097\/HJH.0b013e3282f0580f"},{"key":"1853_CR20","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 2):555\u2013576","DOI":"10.1542\/peds.114.2.S2.555"},{"key":"1853_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","volume":"36","author":"DM Rabi","year":"2020","unstructured":"Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L et al (2020) Hypertension Canada\u2019s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol 36:596\u2013624. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.086","journal-title":"Can J Cardiol"},{"key":"1853_CR22","first-page":"8","volume":"646","author":"WHO Expert Committee on Diabetes Mellitus Second Report","year":"1980","unstructured":"WHO Expert Committee on Diabetes Mellitus Second Report (1980) Tech Rep Ser 646:8\u201314","journal-title":"Tech Rep Ser"},{"key":"1853_CR23","first-page":"10","volume":"727","author":"WHO Study Group","year":"1985","unstructured":"WHO Study Group (1985) Diabetes mellitus Tech Rep Ser 727:10\u201320","journal-title":"Diabetes mellitus Tech Rep Ser"},{"key":"1853_CR24","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the diagnosis and complications of diabetes mellitus. Diabetes Care 1997; 20: 1183\u20131197.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"1853_CR25","unstructured":"Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus, Geneva 1999, World Health Organization."},{"key":"1853_CR26","doi-asserted-by":"publisher","unstructured":"Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom 2019; 22: 453\u2013471. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.001.","DOI":"10.1016\/j.jocd.2019.07.001"},{"key":"1853_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A (2020) Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev 19:102649. https:\/\/doi.org\/10.1016\/j.autrev.2020.102649","journal-title":"Autoimmun Rev"},{"key":"1853_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"Bartalena L (2013) Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9:724\u2013734. https:\/\/doi.org\/10.1038\/nrendo.2013.193","journal-title":"Nat Rev Endocrinol"},{"key":"1853_CR29","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA Di Meglio","year":"2018","unstructured":"Di Meglio LA, Evans-Molina C, Oram RA (2018) Type 1 diabetes. Lancet 391:2449\u20132462. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5","journal-title":"Lancet"},{"key":"1853_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1365-2265.2012.04337.x","volume":"77","author":"KH Mortesen","year":"2012","unstructured":"Mortesen KH, Andersen NH, Hjerrild BE, H\u00f8rlyck A, Stochholm K, H\u00f8jbjerg GC (2012) Carotid intima-media thickness in increased in Turner Syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and estrogen treatment. Clin Endocrinol 77:844\u2013851. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04337.x","journal-title":"Clin Endocrinol"},{"key":"1853_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijcard.2020.10.009","volume":"325","author":"AT Yetman","year":"2021","unstructured":"Yetman AT, Bisselou KSM, Sanmann JN, Katz RJ, Steingraeber CJ, Wilde M, Murray M, Starr LJ (2021) Vascular dissection in women with Turner Syndrome. Int J Cardiol 325:127\u2013131. https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.009","journal-title":"Int J Cardiol"},{"key":"1853_CR32","doi-asserted-by":"publisher","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206\u201352. https:\/\/doi.org\/10.1161\/01.HYP.0000107251.49515.c2.","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"1853_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2265.2000.00960.x","volume":"52","author":"NC Nathwani","year":"2000","unstructured":"Nathwani NC, Unwin R, Brook CG, Hindmarsh PC (2000) Blood pressure and Turner Syndrome. Clin Endocrinol (Oxf) 52:363\u2013370. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00960.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1853_CR34","doi-asserted-by":"publisher","unstructured":"Sandahl K, Wen J, Erlandsen M, Andersen NH, Claus H Gravholt CH. Natural history of hypertension in Turner Syndrome during a 12-year pragmatic interventional study. hypertension 2020; 76: 1608\u20131615. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15292.","DOI":"10.1161\/HYPERTENSIONAHA.120.15292"},{"key":"1853_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","volume":"156","author":"KH Mortensen","year":"2009","unstructured":"Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH (2009) Increased prevalence of autoimmunity in Turner syndrome\u2014influence of age. Clin Exp Immunol 156:205\u2013210. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03895.x","journal-title":"Clin Exp Immunol"},{"key":"1853_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.27270","volume":"62","author":"KT J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M (2010) Autoimmune diseases in women with Turner\u2019s Syndrome. Arthritis Rheum 62:658\u2013666. https:\/\/doi.org\/10.1002\/art.27270","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1853_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fendo.2019.00511","volume":"30","author":"M Wegiel","year":"2019","unstructured":"Wegiel M, Antosz A, Gieburowska J, Szeliga K, Hankus M, Grzybowska-Chlebowczyk U, Wiecek S, Malecka-Tendera E, Gawlik A (2019) Autoimmunity Predisposition in Girls With Turner Syndrome. Front Endocrinol (Lausanne) 30(10):511. https:\/\/doi.org\/10.3389\/fendo.2019.00511","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1853_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-5751-6-10","volume":"6","author":"AE Stenberg","year":"2007","unstructured":"Stenberg AE, Sylven L, Hedstrand H, Kampe O, Hultcrantz M (2007) Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison\u2019s disease in girls and women with Turner Syndrome. J Negat Results Biomed 6:10. https:\/\/doi.org\/10.1186\/1477-5751-6-10","journal-title":"J Negat Results Biomed"},{"key":"1853_CR39","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3389\/fimmu.2018.02279","volume":"9","author":"VR Moulton","year":"2018","unstructured":"Moulton VR (2018) Sex Hormones in Acquired Immunity and Autoimmune Disease. Front Immunol 9:2279. https:\/\/doi.org\/10.3389\/fimmu.2018.02279","journal-title":"Front Immunol"},{"key":"1853_CR40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1359\/jbmr.2000.15.10.2005","volume":"15","author":"A Carrascosa","year":"2000","unstructured":"Carrascosa A, Gussiny\u00e9 M, Terradas P, Yeste D, Aud\u00ed L, Vicens-Calvet E (2000) Spontaneous, but not induced, puberty permits adequate bone acquisition in adolescent Turner Syndrome patients. J Bone Miner Res 15:2005\u20132010. https:\/\/doi.org\/10.1359\/jbmr.2000.15.10.2005","journal-title":"J Bone Miner Res"},{"key":"1853_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1507\/endocrj.EJ20-0083","volume":"67","author":"T Itonaga","year":"2020","unstructured":"Itonaga T, Koga E, Nishigaki S, Kawai M, Sakakibara H, Hasegawa Y (2020) A retrospective multicenter study of bone mineral density in adolescents and adults with Turner Syndrome in Japan. Endocr J 67:1023\u20131028. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0083","journal-title":"Endocr J"},{"key":"1853_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/13697137.2017.1325461","volume":"20","author":"HH Nguyen","year":"2017","unstructured":"Nguyen HH, Wong P, Strauss BJ, Jones G, Ebeling PR, Milat F, Vincent A (2017) Delay in estrogen commencement is associated with lower bone mineral density in Turner Syndrome. Climateric 20:436\u2013441. https:\/\/doi.org\/10.1080\/13697137.2017.1325461","journal-title":"Climateric"},{"key":"1853_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00198-020-05652-1","volume":"32","author":"S Saito","year":"2021","unstructured":"Saito S, Koga E, Okada Y, Tsuburai T, Yoshikata H, Miyagi E, Sakakibara H (2021) Effects of age at estrogen replacement therapy initiation on trabecular bone score in Japanese adults with Turner Syndrome. Osteoporos Int 32:671\u2013680. https:\/\/doi.org\/10.1007\/s00198-020-05652-1","journal-title":"Osteoporos Int"},{"key":"1853_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01760-3","author":"M Chiarito","year":"2022","unstructured":"Chiarito M, Piacente L, Chaoul N, Pontrelli P, D\u2019Amato G, Grandone A, Russo G, Street ME, Wasniewska MG, Brunetti G, Faienza MF (2022) Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner Syndrome. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-022-01760-3","journal-title":"J Endocrinol Invest"},{"key":"1853_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.maturitas.2019.09.010","volume":"130","author":"A Augoulea","year":"2019","unstructured":"Augoulea A, Zachou G, Lambrinoudaki I (2019) Turner Syndrome and osteoporosis. Maturitas 130:41\u201349. https:\/\/doi.org\/10.1016\/j.maturitas.2019.09.010","journal-title":"Maturitas"},{"key":"1853_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12020-017-1336-z","volume":"59","author":"D Ibarra-Gasparini","year":"2018","unstructured":"Ibarra-Gasparini D, Altieri P, Scarano E, Perri A, Morselli-Labate AM, Pagotto U, Mazzanti L, Pasquali R, Gambineri A (2018) New insights on diabetes in Turner Syndrome: results from an observational study in adulthood. Endocrine 59:651\u2013660. https:\/\/doi.org\/10.1007\/s12020-017-1336-z","journal-title":"Endocrine"},{"key":"1853_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000089318","volume":"64","author":"L Mazzanti","year":"2005","unstructured":"Mazzanti L, Bergamaschi R, Castiglioni L, Zappulla F, Pirazzoli P, Cicognani A (2005) Turner Syndrome, insulin sensitivity and growth hormone treatment. Horm Res 64:51\u201357. https:\/\/doi.org\/10.1159\/000089318","journal-title":"Horm Res"},{"key":"1853_CR48","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1210\/jc.2007-2266","volume":"93","author":"N Wooten","year":"2008","unstructured":"Wooten N, Bakalov VK, Hill S, Bondy CA (2008) Reduced abdominal adiposity and improved glucose tolerance in growth hormone treated girls with Turner syndrome. J Clin Endocrinol Metab 93:2109\u20132114. https:\/\/doi.org\/10.1210\/jc.2007-2266","journal-title":"J Clin Endocrinol Metab"},{"key":"1853_CR49","unstructured":"Schellhas HF. Malignant potential of the dysgenetic gonad. Part 1. Obstetrics and Gynecology 1974; 44: 298\u2013309."},{"key":"1853_CR50","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jcem.85.9.6800","volume":"85","author":"CH Gravholt","year":"2000","unstructured":"Gravholt CH, Fedder J, Naeraa RW, Muller J (2000) Occurrence of gonadoblastoma in females with Turner Syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 85:3199\u20133202. https:\/\/doi.org\/10.1210\/jcem.85.9.6800","journal-title":"J Clin Endocrinol Metab"},{"key":"1853_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ajmg.a.30569","volume":"135","author":"L Mazzanti","year":"2005","unstructured":"Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, Nicoletti A, Mencarelli F, Pittalis M, Forabosco A et al (2005) Gonadoblastoma in Turner Syndrome and Y-chromosome derived material. Am J Med Genet 135:150\u2013154. https:\/\/doi.org\/10.1002\/ajmg.a.30569","journal-title":"Am J Med Genet"},{"key":"1853_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejmg.2016.03.005","volume":"59","author":"D Larizza","year":"2016","unstructured":"Larizza D, Albanesi M, De Silvestri A, Accordino G, Brazzelli V, Maff\u00e8 Carnevale G, Calcaterra V (2016) Neoplasia in Turner Syndrome. Eur J Med Genet 59:269\u2013273. https:\/\/doi.org\/10.1016\/j.ejmg.2016.03.005","journal-title":"Eur J Med Genet"},{"key":"1853_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00005537-199701000-00019","volume":"107","author":"A Wirtschafter","year":"1997","unstructured":"Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM et al (1997) Expression of RET \/ PTC fusion gene as a marker for papillary carcinoma in Hashimoto\u2019s thyroiditis. Laryngoscope 107:95\u2013100. https:\/\/doi.org\/10.1097\/00005537-199701000-00019","journal-title":"Laryngoscope"},{"key":"1853_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/eje.1.01988","volume":"153","author":"P Cabanas","year":"2005","unstructured":"Cabanas P, Garcia-Caballero T, Barreiro J, Castro-Feijoo L, Gallego R, Arevalo T, Canete R, Pombo M (2005) Papillary thyroid carcinoma after recombinant GH therapy for Turner Syndrome. Eur J Endocrinol 153:499\u2013502. https:\/\/doi.org\/10.1530\/eje.1.01988","journal-title":"Eur J Endocrinol"},{"key":"1853_CR55","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2265.2007.02807.x","volume":"66","author":"M El-Mansoury","year":"2007","unstructured":"El-Mansoury M, Barrenas ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K (2007) Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner Syndrome. Clin Endocrinol 66:744\u2013751. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02807.x","journal-title":"Clin Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01853-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01853-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01853-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:14:43Z","timestamp":1668028483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01853-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01853-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. The corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the University Hospital of Bologna.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each participant gave their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}